Coherus BioSciences Inc.

14.11-0.1800-1.26%Vol 463.07K1Y Perf -15.64%
Jun 15th, 2021 16:00 DELAYED
BID14.10 ASK14.12
Open14.25 Previous Close14.29
Pre-Market- After-Market14.11
 - -  - -%
Target Price
25.00 
Analyst Rating
Strong Buy 1.00
Potential %
77.18 
Finscreener Ranking
★+     43.98
Insiders Trans % 3/6/12 mo.
-/-82/-94 
Value Ranking
     40.01
Insiders Value % 3/6/12 mo.
-79/-97/-99 
Growth Ranking
     38.28
Insiders Shares Cnt. % 3/6/12 mo.
-79/-97/-99 
Income Ranking
 —    -
Market Cap1.07B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
12.98 
Earnings Date
5th Aug 2021

Today's Price Range

13.9814.27

52W Range

12.9022.22

5 Year PE Ratio Range

-2.7019.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
4.52%
1 Month
-6.74%
3 Months
-11.65%
6 Months
-19.05%
1 Year
-15.64%
3 Years
-4.66%
5 Years
-11.87%
10 Years
-

TickerPriceChg.Chg.%
CHRS14.11-0.1800-1.26
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Financial StrengthValueIndustryS&P 500US Markets
2.10
2.40
0.71
3.27
-2.30
Leverage Ratio 3.50
ProfitabilityValueIndustryS&P 500US Markets
91.30
-11.60
-10.90
-
-18.39
RevenueValueIndustryS&P 500US Markets
442.68M
5.84
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 20210.09-2.37-2 733.33
Q04 20200.250.12-52.00
Q03 20200.350.33-5.71
Q02 20200.260.70169.23
Q01 20200.440.5422.73
Q04 20190.680.53-22.06
Q03 20190.360.6375.00
Q02 2019-0.080.32500.00
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.18-280.00Negative
9/2021 QR-0.11-210.00Negative
12/2021 FY-2.63-757.50Negative
12/2022 FY-0.63-275.00Negative
Next Report Date5th Aug 2021
Estimated EPS Next Report-0.18
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume463.07K
Shares Outstanding75.75M
Trades Count5.42K
Dollar Volume46.24M
Avg. Volume1.15M
Avg. Weekly Volume659.00K
Avg. Monthly Volume805.69K
Avg. Quarterly Volume883.72K

Coherus BioSciences Inc. (NASDAQ: CHRS) stock closed at 14.11 per share at the end of the most recent trading day (a -1.26% change compared to the prior day closing price) with a volume of 465.48K shares and market capitalization of 1.07B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 317 people. Coherus BioSciences Inc. CEO is Dennis M. Lanfear.

The one-year performance of Coherus BioSciences Inc. stock is -15.64%, while year-to-date (YTD) performance is -18.81%. CHRS stock has a five-year performance of -11.87%. Its 52-week range is between 12.9 and 22.22, which gives CHRS stock a 52-week price range ratio of 12.98%

Coherus BioSciences Inc. currently has a PE ratio of -11.70, a price-to-book (PB) ratio of 8.60, a price-to-sale (PS) ratio of 2.48, a price to cashflow ratio of 8.50, a PEG ratio of 2.32, a ROA of -12.82%, a ROC of -12.53% and a ROE of -51.72%. The company’s profit margin is -18.39%, its EBITDA margin is -10.90%, and its revenue ttm is $442.68 Million , which makes it $5.84 revenue per share.

Of the last four earnings reports from Coherus BioSciences Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. Coherus BioSciences Inc.’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for Coherus BioSciences Inc. is Strong Buy (1), with a target price of $25, which is +77.18% compared to the current price. The earnings rating for Coherus BioSciences Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Coherus BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Coherus BioSciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.71, ATR14 : 0.56, CCI20 : 118.19, Chaikin Money Flow : -0.14, MACD : -0.06, Money Flow Index : 75.37, ROC : 7.14, RSI : 53.84, STOCH (14,3) : 68.36, STOCH RSI : 0.54, UO : 53.11, Williams %R : -31.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Coherus BioSciences Inc. in the last 12-months were: Dennis M. Lanfear (Option Excercise at a value of $138 232), Dennis M. Lanfear (Sold 31 054 shares of value $421 229 ), Jean-Frederic Viret (Option Excercise at a value of $496 640), Jean-Frederic Viret (Sold 61 685 shares of value $1 231 881 ), Mary T. Szela (Option Excercise at a value of $569 800), Mary T. Szela (Sold 109 994 shares of value $1 933 519 ), Mats Wahlstrom (Sold 400 000 shares of value $6 860 040 ), McDavid Stilwell (Buy at a value of $49 668), Vincent R. Anicetti (Option Excercise at a value of $2 243 716), Vincent R. Anicetti (Sold 195 171 shares of value $3 527 654 ), Vladimir Vexler (Option Excercise at a value of $919 908), Vladimir Vexler (Sold 181 378 shares of value $3 077 412 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
9 (100.00 %)
8 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Coherus BioSciences Inc.

Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.

CEO: Dennis M. Lanfear

Telephone: +1 650 649-3530

Address: 333 Twin Dolphin Drive, Redwood City 94065, CA, US

Number of employees: 317

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

59%41%

Bearish Bullish

50%50%

News

Stocktwits